HS

Heiko SCHUSTER

IG Immatics Biotechnologies Gmbh: 55 patents #6 of 48Top 15%
📍 Rötteln, DE: #5 of 26 inventorsTop 20%
Overall (2021): #218 of 548,734Top 1%
55
Patents 2021

Issued Patents 2021

Showing 26–50 of 55 patents

Patent #TitleCo-InventorsDate
11020434 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11020433 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11014972 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-05-25
11013766 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11013768 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11013769 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-25
11001617 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-05-11
10993964 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-04
10993962 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-05-04
10954281 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-03-23
10946081 *03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche +2 more 2021-03-16
10925947 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche +2 more 2021-02-23
10905720 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-02-02
10905719 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-02-02
10898518 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-26
10899820 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Janet Peper, Kevin Roehle, Phillipp Wagner, Hans-Georg Rammensee 2021-01-26
10899814 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899813 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899812 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899811 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10899810 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10898519 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-26
10894064 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-19
10888582 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888587 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Janet Peper, Philipp Wagner, Hans-Georg Rammensee 2021-01-12